These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 3379369

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Cholesterol: how and when to treat it?].
    Masana Marín L.
    Med Clin (Barc); 1985 Oct 05; 85(10):423-5. PubMed ID: 4079497
    [No Abstract] [Full Text] [Related]

  • 4. [Statins in primary prevention of coronary heart disease].
    Paulweber B.
    Wien Med Wochenschr; 1999 Oct 05; 149(5-6):129-38. PubMed ID: 10408004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z, Undas R.
    Przegl Lek; 1998 Oct 05; 55(7-8):382-7. PubMed ID: 10021881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-molecular-weight hydroxypropylmethylcellulose. A cholesterol-lowering agent.
    Dressman JB, Adair CH, Barnett JL, Berardi RR, Dunn-Kucharski VA, Jarvenpaa KM, Parr DD, Sowle CA, Swidan SZ, Tobey SW.
    Arch Intern Med; 1993 Jun 14; 153(11):1345-53. PubMed ID: 8507125
    [Abstract] [Full Text] [Related]

  • 10. [The 10-minute consultation: accidently discovered hypercholesteremia].
    Tatò F.
    MMW Fortschr Med; 2004 Sep 02; 146(35-36):59-60. PubMed ID: 15540545
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipoproteins and coronary heart disease.
    Krauss RM.
    Postgrad Med; 1989 Apr 02; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 02; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.
    Grover SA, Dorais M, Coupal L.
    Epidemiology; 2003 May 02; 14(3):315-20. PubMed ID: 12859032
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.